Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOWTIE: Surgery vs PDT vs 5-FU for Bowen's Disease
NCT03909646Phase 4Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- May 2019
- Primary completion
- Mar 2022
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of methyl aminolevulinate, fluorouracil 5% cream in squamous cell carcinoma in situ (SCCIS), sponsored by Maastricht University Medical Center+. Started May 2019; status: completed.
02
Drugs
methyl aminolevulinatefluorouracil 5% cream
03
Conditions
squamous cell carcinoma in situ (SCCIS)
Beyond the preview
Go deeper on NCT03909646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03909646.